ORCID
- Carroll, Camille: 0000-0001-7472-953X
Abstract
We read with interest the report by Santiago et al. [1], demonstrating that clinician decision making regarding the management of motor symptoms of Parkinson’s disease (PD) can be enhanced by home-based, continuous objective measurement. Within the UK National Health Service, we have also been using the Parkinson’s Kinetigraph (PKG) since 2015. Similar to the Santiago cohort, in routine care, physicians target PKG use in patients they believe continuous objective measurement will improve the value of clinical encounters. With support from Parkinson’s UK, we have carried out an evaluation of utility across seven centers from the Parkinson’s Excellence Network, comprising a mix of local services and regional specialist neuroscience centers led by consultant neurologists, geriatricians or Parkinson’s nurse specialists.
DOI
10.3233/jpd-191623
Publication Date
2019-07-30
Publication Title
Journal of Parkinson's Disease
Volume
9
Issue
3
ISSN
1877-7171
Embargo Period
2024-01-04
Organisational Unit
Peninsula Medical School
First Page
601
Last Page
601
Recommended Citation
Carroll, C., Kobylecki, C., Silverdale, M., & Thomas, C. (2019) 'Impact of Quantitative Assessment of Parkinson’s Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions', Journal of Parkinson's Disease, 9(3), pp. 601-601. Available at: https://doi.org/10.3233/jpd-191623
